David A. Williams

• Harvard Stem Cell Institute

• Boston Children's Hospital

  Chief of hematology / oncology

Sources: doi.org, reporter.nih.gov

• National Heart, Lung, and Blood Institute

  UH3, A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia, UH3HL157564, 2022–2029, 27 Mar 2025

Sources: reporter.nih.gov